MSR109 Multi-Indication Evidence Synthesis in Oncology Health Technology Assessment: Case-Study on Bevacizumab

Abstract

Authors

J. Singh S. Anwer P. Saramago S. Palmer A. Thomas S. Dias M. Soares S. Bujkiewicz

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×